Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase

Abraham, M. J., Lindahl, D., van der Spoel, E., Hess, B. & the GROMACS development team. (2014). GROMACS User Manual version, 5(2), 1–298.

10.1080/07391102.2018.1456975

10.1080/07391102.2019.1700167

10.1016/j.imu.2019.100216

10.1093/bioinformatics/btq662

10.1021/j100308a038

10.1093/nar/28.1.235

10.1038/nprot.2008.197

10.1016/S0140-6736(13)61221-0

10.1186/1471-2105-10-421

10.1517/14656566.2014.889116

Centers for Disease Control and Prevention. (2020). Severe outcomes among patients with coronavirus disease 2019 (COVID-19) — United States, February 12–March 16, 2020.

10.1074/jbc.M510745200

10.1371/journal.ppat.1002294

10.1021/jp807056c

10.1002/pro.5560020916

10.1007/82_2017_25

10.1016/j.jhep.2015.10.005

10.3390/ijms20061375

10.2147/AABC.S70333

10.1016/S0140-6736(20)30183-5

Johns Hopkins CSSE. (2020). Coronavirus COVID-19 global cases by Johns Hopkins CSSE. Retrieved March 28, 2020 from https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6

10.1038/nrd1549

10.1093/nar/gks493

10.1002/prot.22570

10.1002/pro.3289

10.1107/S0021889892009944

10.1074/jbc.M110.120014

10.1038/356083a0

Madhav N., 2017, Disease control priorities: Improving health and reducing poverty, 3

10.1016/j.sbi.2018.12.011

10.1097/QAI.0b013e318157131c

10.1016/j.virusres.2014.09.009

10.1128/JVI.03571-13

10.1016/j.plrev.2012.10.009

10.1038/nrd.2018.168

10.1016/S0022-2836(63)80023-6

10.1016/S0140-6736(17)32340-1

10.1107/S0907444904011679

10.1016/j.tim.2016.03.003

10.1001/jama.2015.1328

10.1002/jcc.21334

UCLA MBI. The structure analysis and verification server. Retrieved from https://servicesn.mbi.ucla.edu/SAVES/

10.1056/NEJMoa1215541

10.1093/nar/gky427

10.1016/b978-0-12-385885-6.00009-2

10.1093/nar/gkx1037

World Health Organization (2003, December). Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Retrieved March 28, 2020 from http://www.who.int/csr/sars/country/table2004_04_21/en/index.html

World Health Organization. (2019, November). Middle East respiratory syndrome coronavirus (MERS-CoV). Retrieved March 28, 2020 from https://www.who.int/emergencies/mers-cov/en/

World Health Organization. (2020a). Naming the coronavirus disease (COVID-19) and the virus that causes it. Retrieved March 28, 2020 from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it

World Health Organization. (2020b). WHO Director-General’s opening remarks at the media briefing on COVID-19 – 3 March 2020. Retrieved March 28, 2020 from https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—3-march-2020

World Health Organization. (2020c). WHO Director-General’s opening remarks at the media briefing on COVID-19 – 11 March 2020. Retrieved March 28, 2020 from https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020

World Health Organization. (2020d). WHO Director-General’s opening remarks at the media briefing on COVID-19 – 18 March 2020. Retrieved March 28, 2020.

World Health Organization. (2020e). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Retrieved March 28, 2020 from https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)

10.1073/pnas.1835675100

10.1056/NEJMoa2001017